Henkel buys FDCA from Avantium NV

Bioplastics specialist Avantium N.V. has inked a 5-year agreement to supply Henkel with plant sugar based furandicarboxylic acid , a building block of PEF bioplastics.

Read more

Vésale Bioscience wins R&D grant

Phage therapy specialist Vésale Bioscience gas bageds €1.8m  from European Innovation Council (EIC) to fight antibiotic resistance (AMR).

Read more

Abionyx Pharma announces success in fighting sepsis-triggered AKI

Abionyx Pharma SA has announced positive data from Phase IIa testing of iCER-001,  a recombinant apoA-I, as a treatment for septic patients at high risk of developing Acute Kidney Injury (AKI)
 

Read more

BioNTech bags Instadeep for £562m

BioNTech SE will pay £562m in cash to acquire its former partner InstaDeep Ltd. to expand its capabilities in AI-based drug discovery.

Read more

Roche withdraws checkpoint blocker from the market

Roche AG’s US subsidiary Genentech Inc has withdrawn its checkpoint inhibitor atezolizumab from the market after disappointing results in bladder cancer.

Read more

Hummingbird and Synaffix in $150m ADC deal

Rational antibody design specialist Hummingbird Bioscience has licenced a cancer target and the modular ADC technology of Dutch Synaffix BV.

Read more

First hints for leukopenia diagnostic in MS

Scientists from the University of Basel and the University Hospital Basel have found that two bacterial species may indicate multiple sclerosis-associated lymphopenia.

Read more

Numares AG cashes in €20m from EIB

The European Investment Bank (EIB) is going to support the AI-platform of NMR/metabolomics diagnostics company Numares AG to improve disease prediction.

Read more